Single-cell analysis reveals immune remodeling of monocytes, NK cells, T cell exhaustion in Long COVID with ME/CFS, 2026, Elahi et al

John Mac

Senior Member (Voting Rights)
Full title: Single-cell analysis reveals immune remodeling of monocytes, NK cells, T cell exhaustion, and Galectin-9–associated depletion of gamma delta and mucosal-associated invariant T cells in Long COVID with ME/CFS

The cellular mechanisms underlying Long COVID (LC) associated with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) remain poorly understood.

We performed single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells collected 12 months after acute COVID-19 infection from female individuals with LC-ME/CFS and recovered (R) individuals.

Comparative analysis was also performed using publicly available scRNA-seq datasets from idiopathic ME/CFS patients.

Based on transcriptional signatures, LC-ME/CFS patients exhibited a marked reduction in naïve CD4⁺ and CD8⁺ T cells, regulatory T cells, MAIT cells, and γδ T cells, accompanied by an expansion of effector T cells.

NK cells displayed reduced frequency and altered activation-associated transcriptional factors, consistent with impaired cytotoxic potentials.

B cells in LC patients exhibited gene expression profiles indicative of heightened activation, while plasma cells revealed a distinct transcriptional subset expressing NK-associated genes.

Platelets and low-density neutrophils were expanded and exhibited enrichment of activated-related transcripts.

Monocyte subsets demonstrated transcriptional skewing characterized by reduced expression of phagocytosis-associated genes and increased expression of pro-inflammatory cytokine-related genes/pathways.

In contrast, idiopathic ME/CFS patients exhibited less pronounced immune alterations at the transcriptional level: while T cell activation was evident, there was no reduction in MAIT or NK cells, nor signs of T cell exhaustion.

Notably, FOXP3 expression was upregulated, and B cells and platelets demonstrated dysregulated signatures in idiopathic ME/CFS.

Mechanistically, we identify Galectin-9–TIM-3 interaction as a potential pathway driving γδ and MAIT cell depletion in LC.

Our results reveal extensive peripheral immune remodeling in LC-ME/CFS, distinct from idiopathic ME/CFS, and support a model of chronic immune activation and dysregulation.

Our findings offer a cellular framework for understanding LC pathogenesis and point to potential biomarkers and therapeutic targets for intervention.

 
So there's no mention of how many patients they studied in this abstract.
We performed single-cell RNA sequencing (scRNA-seq) on peripheral blood mononuclear cells collected 12 months after acute COVID-19 infection from female individuals with LC-ME/CFS and recovered (R) individuals.

Comparative analysis was also performed using publicly available scRNA-seq datasets from idiopathic ME/CFS patients.
Is this a valid method of comparison? Comparing fresh blood against a database in this way?

Edit: I really dislike how they use 'idiopathic MECFS' here. Reminds me too much of the BPS 'idiopathic chronic fatigue' grouping/diagnostic dustbin


Based on transcriptional signatures, LC-ME/CFS patients exhibited a marked reduction in naïve CD4⁺ and CD8⁺ T cells, regulatory T cells, MAIT cells, and γδ T cells, accompanied by an expansion of effector T cells.

NK cells displayed reduced frequency and altered activation-associated transcriptional factors, consistent with impaired cytotoxic potentials.

B cells in LC patients exhibited gene expression profiles indicative of heightened activation, while plasma cells revealed a distinct transcriptional subset expressing NK-associated genes.

Platelets and low-density neutrophils were expanded and exhibited enrichment of activated-related transcripts.

Monocyte subsets demonstrated transcriptional skewing characterized by reduced expression of phagocytosis-associated genes and increased expression of pro-inflammatory cytokine-related genes/pathways.

In contrast, idiopathic ME/CFS patients exhibited less pronounced immune alterations at the transcriptional level: while T cell activation was evident, there was no reduction in MAIT or NK cells, nor signs of T cell exhaustion.

Notably, FOXP3 expression was upregulated, and B cells and platelets demonstrated dysregulated signatures in idiopathic ME/CFS.

Mechanistically, we identify Galectin-9–TIM-3 interaction as a potential pathway driving γδ and MAIT cell depletion in LC.
Interesting that they claim to have found these differences. They don't speculate about potential pathways in non LC MECFS, but that probably was outside the scope of their research. I have no idea who this group are and it's hard to judge their findings from this abstract.
 
Back
Top Bottom